Stryker price target lowered to $410 from $465 at Bernstein

Bernstein lowered the firm’s price target on Stryker (SYK) to $410 from $465 and keeps an Outperform rating on the shares. The firm notes that given Q1 disruption that was a bit more intense than expected, investors’ first thought was that FY26 guidance might be difficult to achieve. But as management outlined revenue-recognition tailwinds and backlogs on capital equipment, it became clear that Stryker has good visibility on the revenue and EPS picture for 2026, argues Bernstein.